Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Index divisors are adjusted to reflect corporate actions and maintain index continuity. This intro explains when adjustments occur and why they matter to portfolios.
7,999 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
As markets shift and inflation cools, retirees at 60 face a critical question: how much monthly income can a $1.1 mil...
A single earnings report is not the end of a story, but it can rewrite it. This article explains how Micron's latest ...
Berkshire Hathaway's giant cash position isn’t just sitting idle. In a high-rate environment, that money can work har...
A surge in 2024 five-percent CDs is quietly lifting Medicare premiums in 2026 through IRMAA, due to income reported t...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
Target tops Q4 earnings expectations on cost discipline while generating robust cash flow. The focus center is target...
Carvana's board approved a 5-for-1 stock split, pending shareholder approval. The move could widen access for retail ...
As AI demand accelerates, one company stands out for investors: TSMC. This article explains why the so-called tsmc mo...
Chevron reports stronger-than-expected Q1 2026 results and advancing Hess synergy-driven production, but investors de...
Three large-cap utilities have pulled back on rate-case concerns and regulatory overhangs. This report grades Edison ...
As markets wobble in mid-2026, retirees rethink growth bets tied to gig-economy platforms. The retirement portfolio c...